Study guide
14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing
NPLEX Part I — Biomedical Sciences Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Pacing, and GEA Strategy
1.1 Overview of NPLEX Part I & NABNE Exam Structure 1.2 Deconstructing Biomedical Clinical Vignettes 1.3 General Exam Areas (GEAs) & Passing Standards
2 Chapter 2: Gross Anatomy & Musculoskeletal System
2.1 Musculoskeletal Anatomy of Upper and Lower Extremities 2.2 Structural Anatomy of Head, Neck, Thorax, and Abdomen 2.3 Pelvic Architecture, Perineal Anatomy, and Articular Structures
3 Chapter 3: Histology & Microscopic Anatomy
3.1 Histology of Epithelial, Connective, and Muscular Tissues 3.2 Microscopic Structure of Gastrointestinal, Renal, and Endocrine Organs 3.3 Microscopic Anatomy of Integument, Lymphoid Tissues, and Respiratory Epithelium
4 Chapter 4: Neuroanatomy & Special Senses
4.1 Cranial Nerves, Nuclei, and Peripheral Distribution 4.2 Spinal Cord Tracts, Brainstem Circuits, and Motor/Sensory Pathways 4.3 Cerebral Cortex, Basal Ganglia, Limbic System, and Autonomic Nervous System 4.4 Neuroanatomy of Vision, Audition, Vestibular Function, and Olfaction/Gustation
5 Chapter 5: Embryology & Developmental Anatomy
5.1 Gametogenesis, Fertilization, Blastulation, and Germ Layer Derivatives 5.2 Organogenesis: Cardiovascular and Respiratory System Development 5.3 Gastrointestinal, Urogenital, and Craniofacial Embryology
6 Chapter 6: Cellular & General Physiology
6.1 Membrane Transport Mechanics, Resting Potentials, and Ion Channels 6.2 Action Potential Propagation and Synaptic Transmission 6.3 Excitation-Contraction Coupling in Skeletal, Cardiac, and Smooth Muscle
7 Chapter 7: Cardiovascular & Respiratory Physiology
7.1 Cardiac Electrophysiology, ECG, and Mechanical Cardiac Cycle 7.2 Hemodynamics, Peripheral Resistance, and Blood Pressure Control 7.3 Pulmonary Mechanics, Lung Volumes, and Gas Exchange Dynamics 7.4 Transport of Oxygen/CO2 and Neural/Chemical Control of Breathing
8 Chapter 8: Renal, Fluid, & Acid-Base Physiology
8.1 Glomerular Filtration Rate and Tubular Reabsorption/Secretion Mechanics 8.2 Countercurrent Multiplication, Osmoregulation, and Urine Concentration 8.3 Body Fluid Compartments, Sodium/Water Homeostasis, and Potassium Dynamics 8.4 Renal & Respiratory Acid-Base Regulation and Compensation Mechanisms
9 Chapter 9: Gastrointestinal, Endocrine, & Reproductive Physiology
9.1 GI Motility, Secretory Functions, Digestion, and Nutrient Absorption 9.2 Hypothalamic-Pituitary Axes, Adrenal Gland, and Thyroid Physiology 9.3 Endocrine Pancreas, Glucose Regulation, Calcium/Phosphate Homeostasis 9.4 Male and Female Reproductive Endocrinology and Menstrual Cycle Regulation
10 Chapter 10: Enzymology, Bioenergetics, & Carbohydrate/Lipid Metabolism
10.1 Enzyme Kinetics, Catalytic Mechanisms, and Vitamin Cofactors 10.2 Glycolysis, Pyruvate Dehydrogenase, TCA Cycle, and Oxidative Phosphorylation 10.3 Glycogen Metabolism, Gluconeogenesis, and Pentose Phosphate Pathway 10.4 Fatty Acid Synthesis, Beta-Oxidation, Ketogenesis, and Lipoprotein Transport
11 Chapter 11: Amino Acid/Nucleotide Metabolism & Clinical Genetics
11.1 Amino Acid Degradation, Transamination, and Urea Cycle Disorders 11.2 Purine and Pyrimidine Synthesis, Salvage, and Gout Pathophysiology 11.3 Mendelian Inheritance, Chromosomal Abnormalities, and Molecular Genetics
12 Chapter 12: Immunology & Immunopathology
12.1 Innate Immune Barriers, Phagocytosis, Cellular Pattern Recognition, and Complement System 12.2 Adaptive Immunity: T-Cell & B-Cell Activation, MHC Restriction, and Antibodies 12.3 Types I-IV Hypersensitivity Reactions and Mechanisms of Autoimmunity 12.4 Immunodeficiency Syndromes, Tumor/Transplant Immunology, and Vaccine Types
13 Chapter 13: Medical Microbiology
13.1 Medical Bacteriology: Gram-Positive, Gram-Negative, and Atypical Bacteria 13.2 Medical Virology: DNA, RNA, Retroviruses, and Viral Pathogenesis 13.3 Medical Mycology: Cutaneous, Systemic, and Opportunistic Fungal Infections 13.4 Medical Parasitology: Protozoan and Helminthic Pathogens
14 Chapter 14: General Pathology & Neoplasia
14.1 Cellular Adaptation, Reversible/Irreversible Injury, Necrosis, and Apoptosis 14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing 14.3 Neoplasia: Benign vs Malignant Features, Carcinogenesis, Oncogenes, and Tumor Suppressors
15 Chapter 15: Systems Pathology & Disease Mechanisms
15.1 Pathophysiology of Atherosclerosis, Heart Failure, COPD, and Pneumonias 15.2 Glomerulonephritis, Inflammatory Bowel Disease, and Hepatorenal Disease Pathophysiology 15.3 Endocrine Disorders, Neurodegenerative Pathology, and Epidemiological Principles 15.4 Hematopoietic System Pathology: Anemias, Coagulopathies, and Hematologic Neoplasms 15.5 Immunological System Pathology: Autoimmune, Amyloid, and Systemic Immune-Mediated Disease 15.6 Integumentary System Pathology: Inflammatory Dermatoses, Blistering Disorders, and Skin Neoplasms 15.7 Musculoskeletal System Pathology: Metabolic Bone Disease, Arthropathies, and Bone Neoplasms 15.8 Reproductive System Pathology: Endocrine, Inflammatory, and Neoplastic Disorders of the Reproductive Tract
14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing
Key Takeaways Explain This Topic AI
Acute inflammation involves vascular changes (vasodilation, permeability gaps in postcapillary venules) and leukocyte extravasation (rolling, adhesion, transmigration, chemotaxis).
Leukocyte extravasation relies on selectins (rolling), integrins LFA-1/VLA-4 binding ICAM-1/VCAM-1 (adhesion, defective in LAD-1), PECAM-1 (diapedesis), and chemoattractants C5a/LTB4/IL-8.
Arachidonic acid metabolites include pro-inflammatory PGE2 (fever/pain) and LTB4/LTC4/LTD4/LTE4, while TNF-alpha and IL-1 drive acute-phase hepatic protein synthesis.
Granulomatous inflammation features epithelioid macrophages and Langhans giant cells, divided into caseating (tuberculosis) and non-caseating (sarcoidosis, Crohn's) types.
Wound healing progresses from hemostasis and inflammation to proliferation (granulation tissue, Type III collagen) and remodeling (MMP replacement with Type I collagen; hypertrophic scar vs keloid).
Last updated: July 2026
14.2 Acute and Chronic Inflammation, Chemical Mediators, and Tissue Healing
Inflammation is the vascular and cellular response of living tissue to injury, infection, or necrosis. Designed to eliminate noxious agents, clear necrotic debris, and initiate tissue repair, inflammation is broadly divided into acute and chronic phases. Mastering the chemical mediators, leukocyte kinetics, and regenerative tissue mechanics is essential for understanding pathology across all organ systems.
Acute Inflammation: Vascular and Cellular Dynamics
Acute inflammation is a rapid, early defense response dominated by neutrophils. It unfolds through coordinated vascular changes followed by leukocyte extravasation. Tissue Injury / Pathogen Exposure
- \u2502
- \u25bc
- Transient Arteriolar Vasoconstriction (Seconds)
- \u2502
- \u25bc
- Vasodilation & Hyperemia (Histamine, Nitric Oxide)
- \u2502
- \u25bc
- Increased Vascular Permeability (Histamine, LTC4/D4/E4)
- \u2502
- \u25bc
- Endothelial Contraction in Postcapillary Venules
- \u2502
- \u25bc
- Stasis & Leukocyte Margination
- Vascular Phase Events
Transient Vasoconstriction: Neurogenic reflex lasting only seconds.
Vasodilation: Arteriolar smooth muscle relaxation driven by histamine and nitric oxide (NO) , leading to increased localized blood flow ( rubor and calor ).
Increased Vascular Permeability: Endothelial cell contraction forms intercellular gaps in postcapillary venules . Mediated by histamine, bradykinin, and leukotrienes C4, D4, and E4. Protein-rich fluid leaks into interstitium causing edema ( tumor ).
Stasis and Margination: Fluid loss concentrates red blood cells, slowing microvascular flow (stasis) and pushing leukocytes toward the vessel margins.
Leukocyte Extravasation: The Multistep Cascade
Extravasation of circulating white blood cells into injured tissue proceeds through four distinct, highly regulated molecular steps:
Step Primary Endothelial Receptors Leukocyte Counter-Receptors Clinical / Pathological Significance
1. Margination & Rolling E-selectin (induced by TNF/IL-1), P-selectin (released from Weibel-Palade bodies). Sialyl-Lewis X carbohydrate ligands. Low-affinity transient interactions causing leukocytes to roll along vessel walls.
2. Firm Adhesion ICAM-1 (Intercellular Adhesion Molecule 1), VCAM-1 . Integrins: LFA-1 (CD11a/CD18), VLA-4 (CD49d/CD29). High-affinity binding triggered by chemokines; defective in Leukocyte Adhesion Deficiency Type 1 (LAD-1) .
3. Transmigration (Diapedesis) PECAM-1 (CD31) located at endothelial cell junctions. PECAM-1 (CD31) . Leukocytes traverse the basement membrane using secreted collagenases to enter interstitium.
4. Chemotaxis Chemoattractants bound to ECM and cell surfaces. G-protein-coupled receptors (GPCRs). Unidirectional migration toward gradient of C5a, LTB4, IL-8, and bacterial N-formyl peptides .
Clinical Pearl — LAD-1 Deficiency: Leukocyte Adhesion Deficiency Type 1 is an autosomal recessive defect in the CD18 integrin subunit (beta-2 integrins). Patients present with delayed separation of the umbilical cord, recurrent bacterial infections without pus formation, and severe peripheral blood neutrophilia (neutrophils cannot extravasate).
Cellular Kinetics of Acute Inflammation
First 6 to 24 Hours: Neutrophils (PMNs) predominate due to their rapid response and high blood concentrations, but they undergo apoptosis after 24–48 hours.
24 to 48 Hours: Macrophages (monocytes) peak, taking over phagocytosis, clearing dead neutrophils, and secreting growth factors to govern repair.
Chemical Mediators of Inflammation
Inflammatory processes are orchestrated by endogenous chemical signals derived from plasma proteins or cellular secretion. Arachidonic Acid (Membrane Phospholipids)
- \u2502
- Phospholipase A2 (Inhibited by Steroids)
- \u2502
\u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2534\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510
- \u25bc \u25bc
- Cyclooxygenase (COX-1/COX-2) 5-Lipoxygenase (5-LOX)
- (Inhibited by NSAIDs/Aspirin) \u2502
- \u2502 \u25bc
\u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u253c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510 Leukotrienes
\u25bc \u25bc \u25bc \u2502
PGE2 PGI2 TXA2 \u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2534\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510
- Fever / Vasodilation / Vasoconstriction/ \u25bc \u25bc
- Pain Inhibits Aggr. Promotes Aggr. LTB4 LTC4, LTD4, LTE4
- Neutrophil Chemotaxis Bronchospasm / Permeability
- Key Vasoactive and Eicosanoid Mediators
Histamine: Preformed in mast cell granules; causes rapid vasodilation and endothelial gap formation in postcapillary venules.
Arachidonic Acid (AA) Metabolites: Freed from cell membranes by Phospholipase A2 (inhibited by glucocorticoids).
Cyclooxygenase (COX) Pathway:
Prostaglandin E2 (PGE2): Mediates fever (acts on hypothalamus) and increases pain sensitivity.
Prostacyclin (PGI2): Synthesized by endothelium; causes vasodilation and inhibits platelet aggregation.
Thromboxane A2 (TXA2): Synthesized by platelets; causes vasoconstriction and promotes platelet aggregation.
Lipoxygenase (LOX) Pathway:
Leukotriene B4 (LTB4): Potent chemoattractant and activator for neutrophils.
Leukotrienes LTC4, LTD4, LTE4: Slow-reacting substances of anaphylaxis; cause severe bronchospasm and marked vascular permeability.
Major Inflammatory Cytokines
TNF-alpha & IL-1: Secreted by activated macrophages. Induce endothelial cell expression of adhesion molecules (selectins/ICAM-1), trigger systemic acute-phase reactions (fever, lethargy), and stimulate hepatic synthesis of acute-phase reactants ( C-reactive protein [CRP] , fibrinogen , serum amyloid A [SAA] ).
Interleukin-6 (IL-6): Stimulates hepatic production of acute-phase proteins and erythrocyte sedimentation rate (ESR) elevation.
Chronic Inflammation and Granuloma Formation
Chronic inflammation is prolonged inflammation (weeks to years) characterized by simultaneous active inflammation, tissue destruction, and repair efforts.
Key Cellular Drivers
Macrophages: Primary effector cells. Classical activation ( M1 pathway , stimulated by IFN-gamma) yields pro-inflammatory, microbicidal macrophages. Alternative activation ( M2 pathway , stimulated by IL-4 and IL-13) yields anti-inflammatory macrophages that promote tissue repair and fibrogenesis.
T Lymphocytes & Plasma Cells: Produce cytokines (IFN-gamma) and antibodies to maintain immune activation.
Granulomatous Inflammation
A specialized subtype of chronic inflammation featuring microscopic aggregates of transformed, expanded macrophages called epithelioid histiocytes and fused Langhans multinucleated giant cells (horseradish-shaped nuclei), bordered by a peripheral rim of lymphocytes.
Granuloma Type Histological Features Major Etiologies
Caseating Granulomas Central zone of acellular, cheesy necrotic debris surrounded by epithelioid histiocytes and giant cells. Tuberculosis , Histoplasmosis, Blastomycosis, Coccidioidomycosis.
Non-Caseating Granulomas Intact central core without necrosis; organized clusters of epithelioid macrophages. Sarcoidosis , Crohn Disease , Berylliosis, Foreign body reactions.
Tissue Repair, Wound Healing, and Complications
Tissue restoration following injury occurs via regeneration (proliferation of uninjured parenchymal cells) or repair (deposition of collagen forming a fibrous scar).
The Four Phases of Cutaneous Wound Healing
Hemostasis Phase (Immediate): Platelet aggregation and activation of the coagulation cascade form a fibrin clot to arrest hemorrhage.
Inflammatory Phase (Days 1–3): Neutrophils infiltrate to clear bacteria, followed by macrophages that phagocytose debris and secrete growth factors ( TGF-beta , VEGF , FGF ).
Proliferative Phase (Days 3–Weeks): Formation of granulation tissue (characterized by proliferating fibroblasts, delicate capillary angiogenesis, and loose Type III collagen deposition). Myofibroblasts mediate wound contraction.
Remodeling Phase (Weeks to Months): Matrix metalloproteinases ( MMPs / collagenases, dependent on zinc ) break down temporary matrix, replacing weak Type III collagen with high-tensile-strength Type I collagen . Tensile strength reaches ~80% of normal by 3 months. Phase 1: Hemostasis Phase 2: Inflammation Phase 3: Proliferation Phase 4: Remodeling
\u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510 \u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510 \u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510 \u250c\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2510
\u2502 Fibrin Clot Formation \u2502\u2500\u2500\u2500>\u2502 Neutrophil / Macrophage\u2502\u2500\u2500\u2500>\u2502 Granulation Tissue, \u2502\u2500\u2500\u2500>\u2502 MMP-Mediated Replacement\u2502
\u2502 & Platelet Plug \u2502 \u2502 Infiltration \u2502 \u2502 Fibroblasts, Type III \u2502 \u2502 of Type III Collagen \u2502
\u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518 \u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518 \u2502 Collagen & Angiogenesis\u2502 \u2502 with Type I Collagen \u2502
\u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518 \u2514\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2518
Complications of Wound Healing: Hypertrophic Scar vs. Keloid
Hypertrophic Scar: Excessive deposition of Type III collagen organized parallel to the epidermis. Crucially, the scar remains confined strictly within the original wound boundaries and often regresses over time.
Keloid: Excessive deposition of broad, disorganized bands of Type I and Type III collagen . Keloids grow beyond the original wound boundaries into surrounding uninjured tissue, rarely regress, and show a strong genetic predisposition in individuals of African, Asian, or Hispanic descent.